All posts by student

Grey’s Anatomy’s Chandra Wilson Opens Up About Her Daughter’s … – PEOPLE.com

As Dr. Miranda Bailey on ABCs Greys Anatomy, Chandra Wilson is used to solving medical mysteries. But when her daughter suddenly came face to face withher own rare disorder, the actress fell straight into detective mode.

After a casual outing with friendswhen she was 16 years old, Sarina McFarlane thought she was fighting a bad case of food poisoning. However, after repetitive attacks of nausea and vomiting, both daughter and motherknew it was something more serious.

She would get these terrible bouts of vomiting and stabbing abdominal pains, Wilson, 47, exclusively tells PEOPLE in this weeks issue. I thought, This was crazy. Something was wrong with my daughter, and nobody could tell me what it was.

For Wilson, watching her daughters struggle nearly got to the point ofunbearable.

I found myself tracking what foods she was eating, where we were, tracking all this information myself, she says. Each hospital visit, I would put the info into a binder. By month eight, I was walking around with this gigantic binder.

After 10frustrating months of unanswered questions and endless hospital visits due to dehydration, McFarlanewas finally diagnosed with mitochondrial dysfunction (severe depletion of the bodys cellular energy supply) andcyclic vomiting syndrome(CVS), a rare disorder that presents with random attacks of committing, nausea, and extreme exhaustion, in 2010.

Now, 23, McFarlane admits she was scared, frustrated and depressed during the months leading to her diagnosis.

People in high school thought I was throwing up because I was trying to lose weight, she says.

The episodes tend to be abrupt, coming at different frequencies, McFarlanes physician, Dr. Richard Boles, the medical director for Courtagen Life Sciences, says. Dueto the symptomslack of diversity, its extremely hard to diagnose.

Theres really no objective criteria to back it up, he says. And, though experts have not found a cure, Boles stresses that it can be controlled with the right medication, vitamins and healthy lifestyle.

As McFarlane made a transition from adolescent care (where she maintained the same group of doctors and nurses) to adult care, her troubles seemed to only get worse.

If you go to the hospital two, three or four times, they think youre a druggie, she says.

You have to go through the process of being believed again, adds Wilson.

Now McFarlane, whos studying screenwriting at Cal State Northridge, and her momtry to remain upbeat.

I could be sad about it, says McFarlane, but its going to come back anyway.

Greys Anatomy airs Thursdays (8 p.m. ET) on ABC.

Excerpt from:
Grey's Anatomy's Chandra Wilson Opens Up About Her Daughter's ... - PEOPLE.com

The Anatomy of the Perfect Cheese Plate – Lifehacker Australia

Illustration by Sam Woolley.

A cheese plate can be many things. A party platter, a snack, even a meala cheese plate can all of these things and more. It doesnt require any cooking, but crafting a perfectly harmonious plate of delicious dairy is a delicate balancing act, and some forethought is required.

It can be easy to go overboard with both cheeses and accouterments, but having a clear vision of the type of cheese plate you want to present to the world can keep you on track. But before you can do that, you need to decide how many cheeses you want to serve.

There are two routes you can take when presenting one cheese. You can choose a crowd-pleaserlike a good sharp cheddar or an excellent wheel of brieor you can go with a slightly more divisive show-stopper like a super funky blue, or the stinky-though-tasty Taleggio. In either case, youll need at least one carby delivery system and one complementary extra. Serious Eats has a good primer on various tasty types of cheese, but here are a few of my favorite ways to let a single cheese shine:

Another good way to focus on one cheese is to bake it or marinate it. Baked brie en croute, goat cheese with tomato sauce, and marinated mozzarella or feta all make great cheesy centerpieces.

Im not a fan of the even-numbered cheese plate for some reason, but if you are only going to serve two cheeses, I would do one hard and one soft, and do them really well. Three is my favorite number to serve however, because it gives you the freedom to throw something wild and crazy into the mix. Here are some of my favorite picks for each category:

To ensure a good variety of flavors, you can try picking one from each cheese-bearing animal (cow, sheep, goat), but Ive used my hard, soft, fun template with much success. (That template seems much dirtier than it actually is, now that Ive typed it out.)

Now that we have our cheeses chosen, were free to think about fun add-ons. It can be very easy to go crazy here, so I try to limit myself to one sweet thing, one salty thing, one sweet saucy thing, and one savory saucy thing. Youll also need bread and crackers.

I know thats a lot of foodie info to take in at once, so well recap real quick: unless you are going the one cheese route we covered earlier, my platonic ideal of a cheese plate is:

1 hard cheese + 1 soft cheese + 1 fun cheese

Served on:

simple toasted toast points + a smattering of seedy or fruity crackers

Paired with:

1 sweet thing + 1 salty thing + 1 sweet saucy thing + 1 salty saucy thing

This may seem like a lot, but Ive never had much in the way of leftovers and, if the unthinkable does happen you are plagued by excess cheese, you can always make cheese crisps or fromage fort. Everyone wins.

Go here to see the original:
The Anatomy of the Perfect Cheese Plate - Lifehacker Australia

ProMIS Neurosciences announces presentation and expert panel participation at the Neuroscience Biopartnering and … – Yahoo Finance

TSX: PMN

TORONTO, March 28, 2017 /CNW/ - ProMIS Neurosciences ("ProMIS" or the "Company"), a company focused on the discovery and development of precision treatments for neurodegenerative diseases, today announced its participation in the 2nd Annual Neuroscience Biopartnering and Investment Forum conference organized by Sachs Associates and held at the New York Academy of Sciences on March 27, 2017.

ProMIS Executive Chairman, Eugene Williams, presented an update and overview on the company's rapid progress and future outlook, and also contributed as a member of the expert panel entitled "Advances in Alzheimer's Disease".

"Following on from the Company's successful fund raise announced in February of this year, ProMIS will focus on progressing the development of its antibody program targeting toxic, prion-like forms of Amyloid beta, a root cause of Alzheimer's. Our lead development product, PMN310, is on track for IND submission at the end of 2018", stated Williams. "Furthermore, there is a substantial body of evidence from prior clinical trials in AD that targeting specifically the toxic, prion-like strains of Amyloid beta, while avoiding targeting of Amyloid beta monomer and plaque, will lead to best in class disease modifying therapy".

The Company overview presented at the meeting is available on the ProMIS Neurosciences website at: http://bit.ly/2na9QPl

About ProMIS Neurosciences, Inc.

The mission of ProMIS Neurosciences is to discover and develop precision medicine therapeutics for effective treatment of neurodegenerative diseases, in particular Alzheimer's disease and ALS.

ProMIS Neurosciences' proprietary target discovery engine is based on the use of two, complementary techniques. The Company applies its thermodynamic, computational discovery platformsProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins. Using this unique "precision medicine" approach, ProMIS Neurosciences is developing novel antibody therapeutics and specific companion diagnostics for Alzheimer's disease and ALS. The company has also developed two proprietary technologies to specifically identify very low levels of misfolded proteins in a biological sample. In addition, ProMIS Neurosciences owns a portfolio of therapeutic and diagnostic patents relating to misfolded SOD1 in ALS, and currently has three preclinical monoclonal antibody therapeutics against this target.

The TSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This information release may contain certain forward-looking information. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company's current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its public securities filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For further information please consult the Company's website at:www.promisneurosciences.com

Follow us onTwitter Like us onLinkedIn

Originally posted here:
ProMIS Neurosciences announces presentation and expert panel participation at the Neuroscience Biopartnering and ... - Yahoo Finance

The new S-Town podcast, from the Serial team, is a real-life Southern gothic – Vox

You are now entering Shit Town.

Thats what the S in S-Town stands for, as we learn in the opening moments of one of the years eeriest new podcasts. The just-launched project is the highly anticipated follow-up to 2014s smash hit Serial, and all seven episodes are available to listen to now.

The details of S-Towns premise have been shrouded in mystery for months. The show was first announced in November, but apart from a few tantalizing hints about murders and treasure hunts, its story was kept largely under wraps.

So the podcasts opening revelation that the S-Town title is a smokescreen for a something much blunter is a perfect setup for the various bluffs, double bluffs, and unexpected U-turns to come. Hosted by This American Life producer Brian Reed, S-Town is about the real life of one man whose attempt to make a difference in his small Alabama community has sweeping, unexpectedly far-reaching repercussions.

Reed spent several years investigating the story, which began with an email from a This American Life fan and evolved into a mystery within a mystery. The story ultimately takes many unique turns that are best left unspoiled, but in the opening act, a man named John convinces Reed to travel to Alabama to help him investigate a murder. From there, Reed gets caught up in the somewhat baffling idiosyncrasies of Shit Town and its residents and above all, in the idiosyncrasies of John himself.

S-Town is the work of podcast royalty: The first podcast to launch under Serials spinoff production company Serial Productions, it is executive-produced by Serial co-creator Julie Snyder, and its editorial team includes longtime This American Life host Ira Glass, Serial host Sarah Koenig, and Starlee Kine, creator of the cult podcast hit Mystery Show.

However, despite its blatant positioning as the heir to the Serial throne, S-Town is not quite the true crime podcast you might be expecting. Instead, its an engrossing narrative about the complexities of human behavior. But there are definitely similarities to Serial and other podcasts that deal in real-life intrigue, like the recent controversial Missing Richard Simmons.

Perhaps inevitably, what seems to be a foray into one mystery abruptly veers into a much larger, more somber, and unexpected tale about how the personal is always political, and how change on an individual level can become change on a universal level.

But it really does include a treasure hunt.

S-Town is now streaming on iTunes, apps like Stitcher, and the S-Town website.

Read more:
The new S-Town podcast, from the Serial team, is a real-life Southern gothic - Vox

Cancer Genetics, Inc. (CGIX) Has Revealed It All In Its Chart – NY Stock News

The technicals for Cancer Genetics, Inc. (CGIX) have taken shape, and with them a comprehensive picture has emerged. This is the current state of play as presented by the current technical setup. Reading the technical chart for a given stock is a vital part of trading and investing success. Unless ample attention is paid to key technical aspects of a stocks pricing and volatility, decisions can at best be considered blind, or worse, idiotic. Getting to grips with all the technical factors that affect price and movement is therefore crucial.

(CGIX) has shown a marked change in trend levels over the course of recent market activity. Based on recent activity surrounding both the 50 and 200 SMAs, theres been a marked trend created which can be described as bullish. The composite picture painted by the trends built around both SMAs has also created a measured analysis of current investor sentiment as the stock navigates upside and downside risk. The established market sentiment toward the stock has created a trading environment which can suitably be described as positive. There has also been a knock-on effect as it relates to trading volume now reflected in strong real-time sentiment on the buying and selling curve; this has created in turn, enthusiasm toward the stock as measured across a broad statistical mix of the general trading community.

As a composite and comprehensive tableau, the stocks position in the minds of the trading market reflects a broad analysis of technicals and inherent trends which underpin overall market-trading viability.

Relative strength indicator (RSI) and Stochastic measures are two very important leading indicators that help traders gauge overall movement of a particular stock; they act as boosters to technical analysis. Together they show in a measured way, whether or not a stock currently overbought or oversold. This indicator is crucial in determining whether traders are tipped toward the side of buying more of the stock, or doing the opposite and selling more of the stock. This is very important directional information necessary for making trading decisions. (CGIX)s current measure for its 14-day RSI is 85.26%; this is suggestive that on balance of the indicator, the stock is currently overbought and may have reached the upper limits of upward movement, perhaps acting as a potential trigger for a price reversal. The stochastic picture presents a complimentary view of overall sentiment in the present state for (CGIX). Stochastic data gathered over the last 30 days has created a score of 91.02%. This indicates that the stock is overbought at current levels.

The successful trader has within her or her arsenal a wide range of tools. The leading indicators mentioned above help make up that arsenal but they are by no means the only ones needed for trading success. Short term indicators, as well as performance indicators, can mean all the difference in executing successful trades. The omens depict a telling picture in terms of the near-term trading setup for (CGIX); this makes things very interesting to the curious and interested eye. The +2.65 has created a positive in the trailing 30 days since initiating movement. Over the extended term, the stock has outperform the S&P 500 by 67.49%. This consistent movement and its attendant overall performance have produced higher daily volatility when compared with other stocks ranking in the same peer group and on the same exchange. The picture looks the same when the stock is assessed against volatility levels measured historically. This historical volatility gives a current reading of 149.35%. These measures of historic volatility are very handy in judging the underlying price momentum and the rate of change in the price of (CGIX). Bound up this picture of volatility, is another measure that gives the underlying thesis for (CGIX). This can best be seen by analyzing the readings for the stocks average true range, currently 13.03. ATR is a fine augment to the other indicators outlined above and should be used in conjunction and not as a standalone.

Read more from the original source:
Cancer Genetics, Inc. (CGIX) Has Revealed It All In Its Chart - NY Stock News

Veritas Genetics to Provide BRCA Testing to Participants in Canadian Breast Cancer Screening Effort – GenomeWeb

NEW YORK (GenomeWeb) Veritas Genetics announced today that it has agreed to provide BRCA testing for men and women who participate in a new initiative called The Screen Project being conducted at Toronto's Women's College Hospital (WCH).

Registering provides access to this and other free content.

Already have an account? .

Read the rest here:
Veritas Genetics to Provide BRCA Testing to Participants in Canadian Breast Cancer Screening Effort - GenomeWeb

Veritas Genetics Collaborates with Dr. Steven Narod and Women’s College Hospital to Launch The Screen Project – a … – PR Newswire (press release)

Approximately 1 in 200 Canadians have a BRCA1 or BRCA2 mutation, which are strongly associated with the development of breast, ovarian and prostate cancers. However, genetic testing for these gene mutations in Canada is only offered to, and covered for, people who meet strict eligibility criteria based on several factors including having a strong family history of cancer. "Population-based genetic testing is a new approach for widespread screening in Canada that we hope will change the current genetic testing paradigm," said Dr. Steven Narod, co-principal investigator and the director of the Familial Breast Cancer Research Unit at WCH.

With The Screen Project, all Canadians, age 18 years and older, will have access to BRCA1 and BRCA2 screening for a fee of $165 USD. Once they enroll online, participants will receive a saliva testing kit at home. Veritas will process their returned samples at the company's laboratory, and the results will be reported to the patient within 2 to 4 weeks. Those who test positive for a BRCA mutation will be contacted by the Familial Breast Cancer Research Unit at WCH and will be offered additional clinical guidance. Those who receive a negative or inconclusive result will be notified through a report from Veritas.

"For years, our research team have been advocating for population-based genetic testing for BRCA1 and BRCA2, the two most clinically actionable susceptibility genes for breast and ovarian cancers. However, this has not been possible until now mostly because of the high cost of the test and the difficulties in participant enrollment," explained Dr. Mohammad Akbari, co-principal investigator of the study and director of the Research Molecular Genetics Laboratory at WCH. "We found Veritas to be the best match for The Screen Project given their ability to enroll patients quickly and at the best price possible."

"We now know using family history as the only selection criteria for genetic testing can make us miss up to half of all individuals who would greatly benefit from early access to this information," said Mirza Cifric, co-founder and CEO of Veritas. "This is the first of several population-based initiatives we at Veritas will be rolling out in various countries over the coming months. It's equally important to mention that these screening efforts will be coupled with the appropriate follow-up clinical care. This is why we are so excited to work with Dr. Narod and Dr. Akbari at WCH. We believe this is the model for future cancer screening."

Currently, Veritas' myBRCA products are available through distributors in more than 30 countries. Individuals in the U.S. who are interested in BRCA testing can learn more at veritasgenetics.com/mybrca.

About Veritas GeneticsVeritas Genetics is a global leader in providing accessible genetic screening and interpretation to individuals, physicians, and medical researchers. By removing barriers to genetic screening and whole genome sequencing, Veritas Genetics empowers individuals and doctors to make informed lifestyle decisions that help people live longer, healthier lives. The company was recognized by MIT Technology Review as one of the "50 Smartest Companies" in 2016. Veritas was founded by leaders in genomics from Harvard Medical School and operates globally from its offices in the U.S., Europe and China. Learn more at veritasgenetics.com.

About Women's College HospitalFor more than 100 years Women's College Hospital (WCH) has been developing revolutionary advances in healthcare. Today, WCH is a world leader in the health of women and Canada's leading, academic ambulatory hospital. A champion of equitable access, WCH advocates for the health of all women from diverse cultures and backgrounds and ensures their needs are reflected in the care they receive. It focuses on delivering innovative solutions that address Canada's most pressing issues related to population health, patient experience and system costs. The WCH Institute for Health System Solutions and Virtual Care (WIHV) is developing new, scalable models of care that deliver improved outcomes for patients and sustainable solutions for the health system as a whole.

Women's College Research Institute (WCRI) is tackling some of the greatest health challenges of our time. Its scientists are conducting global research that advances the health of women and improves healthcare options for all, and are then translating those discoveries to provide much-needed improvements in healthcare worldwide. For more information about how WCH and WCRI are transforming patient care, visit http://www.womenscollegehospital.ca and http://www.womensresearch.ca.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/veritas-genetics-collaborates-with-dr-steven-narod-and-womens-college-hospital-to-launch-the-screen-project---a-population-based-brca-screening-initiative-across-canada-300430320.html

SOURCE Veritas Genetics

http://www.veritasgenetics.com

Link:
Veritas Genetics Collaborates with Dr. Steven Narod and Women's College Hospital to Launch The Screen Project - a ... - PR Newswire (press release)

Large-scale study finds genetic errors associated with brain cancer – Medical News Today

Hundreds of thousands of people in the United States are living with a brain tumor. Gliomas are a particular category of malignant brain tumor that includes glioblastoma - a tumor with a low survival rate. New research uncovers genetic variants associated with an increased risk of glioma.

A new genetic study carried out by a team of international researchers from the United Kingdom, Europe, and the U.S. identifies 13 new genetic errors that correlate with a high risk of glioma. The findings were published in the journal Nature Genetics.

The National Brain Tumor Society estimate that 688,096 U.S. individuals have a brain tumor, and nearly 140,000 of these are malignant.

Brain tumors are quite aggressive and difficult to treat, with an average of only 34.4 percent of the patients surviving 5 years after their initial diagnosis.

Of the different types of brain tumor, glioma is the most common. It describes a type of tumor that grows from the brain's glial cells, which can be found around the neurons, supporting the nerve cells.

Across all brain tumors, gliomas account for approximately 27 percent and are estimated to cause 13,000 yearly cancer deaths in the U.S., according to research quoted in the new study. Gliomas are usually divided into glioblastomas (GBMs) and non-GBM tumors. Patients diagnosed with GBMs have a survival rate as low as 5 percent.

The authors of the new study note that little is known about the environmental factors that contribute to the risk of being diagnosed with glioma. The researchers set out to examine the genetic background for glioma risk.

The team conducted two new genomic studies and added their findings to that of previously existing studies. The result was a meta-analysis of almost 12,500 people with glioma and more than 18,000 healthy, glioma-free controls.

Overall, the scientists identified 13 new genetic variants that raised the risk of glioma: five new loci were identified for GBM, and eight for non-GBM tumors. The study shows that these genetic errors impact various cell functions, including the genesis and division of neurons, cell cycle regulation, DNA repair, and the production of some proteins.

Additionally, the scientists examined how different genetic strands affect a person's chances of developing GBM and non-GBM tumors.

For instance, they found that the expression of the HEATR3 gene increases the risk of GBM by 18 percent, but it has a much lower impact on non-GBM risk.

Study co-leader Richard Houlston, professor of molecular and population genetics at the Institute of Cancer Research in London in the U.K., comments on the significance of these findings:

"The changes in the way we think about glioma could be quite fundamental," Prof. Houston explains. "So for example, what we thought of as two related subtypes of the disease turn out to have quite different genetic causes which may require different approaches to treatment."

Apart from the newly discovered genetic errors, the study also confirmed the role of other genes that have been previously identified and correlated with the risk of brain and other types of cancer.

Before the new study, the total number of genetic variants linked to glioma risk was 13. The new research doubles this number.

"It has been exciting to have been involved in such a gigantic study including cases of brain cancer from all over the world. We have uncovered a treasure trove of new information about the genetic causes of glioma brain cancers.

Understanding the genetics of glioma in such detail allows us to start thinking about ways of identifying people at high inherited risk, and will open up a search for new treatments that exploit our new knowledge of the biology of the disease."

Prof. Richard Houlston

Learn how scientists inhibit brain tumor cell growth and how it could pave the way for new treatment.

More here:
Large-scale study finds genetic errors associated with brain cancer - Medical News Today

Weekly genetics review: Gender equality being seen in seedstock industry – Beef Central

WHILE bulls have long been the main provider of genetic power, embryo transfer is just one tool which has lifted the influence of the female side of the pedigree equation.

Not only has ET been the multiplier of a herds top female genetics, it has lifted the overall quality of herds that use it. The result: a surplus becoming available of top females carrying the same genetics as their replacement heifers.

This weeks genetics report continues on from the theme we established last week: the role that registered female sales are currently having in some seedstock enterprises.

Despite 400mm of rain since January generating good feed at Ascot Cattle Cos Warwick, Queensland, headquarters, North Toolburra, and spill-over available at a second company property near Glen Innes, in NSW, the options this year were to sell some registered Angus and Charolais females or buy another property.

The first option was taken, and the 77 heifers offered at Ascots autumn sale last Friday grossed $235,000, delivering 43 percent of the overall sale gross.

Jim Wedge & Jackie Chard from Ascot Cattle Co, North Toolburra, Warwick

Co-principal Jim Wedge was pleased with the result. It was either sell them as registered females or chop their heads off and be wasted to the industry, he said.

Ascot is a 100pc registered herd running up to 700 breeders, with roughly equal numbers of Angus and Charolais, but trending towards Angus.

About 60pc of the Ascot heifers sold last week went to commercial producers and smaller studs. It is suspected some of the heifers also went to large commercial operations, many of which breed some replacement bulls for their own use.

We end up with around 300 heifer calves a year and we keep about 20pc as replacements, so we do have some surplus that are of excellent quality. We use the very best AI sires and back up bulls so the surplus heifers carry the same genetics as our replacements, Mr Wedge said.

The success of this first sale of females ensures the offering remains an important part of their smaller autumn bull sale, with the Ascot spring bull sale remaining the major bull selling event.

Armidale NSW based independent stud stock agent Mike Wilson said adding some registered females to a bull sale catalogue was one relatively easy way to make some extra money.

Once youd be flat out getting much more than commercial value for registered females, but these days we are seeing stud females bringing double or triple what commercial females are bringing, he said.

At one recent sale, young heifers, some joined and some not, had a reserve of $2000 and they finished up averaging more than $3000, Mr Wilson said.

Another example was a well-known Angus and Hereford breeder in central New South Wales who had a production sale of surplus registered females, generating enough to buy another property and set his son up.

But Mike Wilson had a note of caution. It only works for studs with a decent name, top line studs with good reputations that have genuine quality females to sell, he said.

Blake Munro

Queensland-based Elders agent Blake Munro said he would not call the additional registered females coming on the market presently a trend.

Weve all seen it: studs taking advantage of a buoyant cattle market, other studs buying up special genetics and commercial herds upgrading, he said.

Cashed-up commercial producers buying in a few better quality heifers to improve herds is certainly happening.

Another good example of the strong current demand for registered females, according to Mr Munro, is David and Prue Bondfields Palgrove Charolais Stud on the Qld/NSW border, which enjoyed a successful female sale earlier this month.

Palgrove does not hold an annual female sale, but its one held when conditions are right and surplus females are available, Mr Munro said.

One of the worlds most influential Angus seedstock producers, Gardiner Angus Ranch (GAR), lost 500 cattle in the last weeks wildfires in the state of Kansas in the US.

The giant GAR operation, which has a strong influence in the Australias Angus population, sells around 1000 bulls at three annual auctions, which in 2016 grossed close to $9 million for bulls and registered females.

Greg Gardiner with Angus heifers salvaged from the recent fires on Gardiner Ranch in Kansas

Five generations of Gardiners have been through droughts, blizzards and snow storms but the recent fire will go down as the familys most challenging event ever. The usual lush green cover at this time of the year has been replaced with black charred country and blowing sand reported the Drovers Cattle Network.

None of us thought the fire had this breadth and scope to it and it could do what it did, said Greg Gardiner. This is something weve never seen in our lifetime.

Fortunately, there were no lives lost at GAR, but his brother, Marks home was burnt to the ground.

Of GARs 19,200 hectares of country, 16,800ha were grass and virtually all that was burned. The ranch also lost 6000 large round bales of hay that were strategically stored over an 8km stretch, so that not all would be lost in the case of a fire.

The 500 destroyed cattle were not insured, according to Drovers Cattle Network.

On the brighter side, GARs valuable donor cows survived the fire, saving multiple generations of genetics.

If we would have lost those genetics, we would be up the river, said Greg Gardiner.

GARs biggest sale of the year is this coming Saturday, April 1, when 1025 head including 420 bulls, 377 registered females and 150 commercial females have been catalogued. At last years April sale bulls averaged $US8826 and registered females averaged $US6090.

US media sources indicated that the April 1 sale will proceed.

Go here to read the rest:
Weekly genetics review: Gender equality being seen in seedstock industry - Beef Central

5 Reasons To Stop Calling Dads Of Unborn Babies A ‘Father To Be’ – The Federalist

Every parent I know has developed a pregnancy pet-peeve. Most women I know have said theirs was unwanted touching of their blossoming baby bump.For my pregnant wife, its how total strangers suddenly feel the need to explain how little sleep were going to get once baby is born.

I dont mind that so much, because I assume these are well-intentioned people trying to prepare us for an event we simply cannot understand yet. No, my pregnancy pet peeve was being called a father-to-be.

The peeve began to develop very early. When I announced to my co-workers that my wife is pregnant, they were happy for us. They asked about the due date and whether we were having a boy or a girl. And they congratulated me: Youre going to be a dad! they said, in the future tense.

I soon became very sensitive to this phrase. But I gave my co-workers the benefit of the doubt. Maybe Im just being a grammar nerd, I thought. Certainly this wont be something I hear that often.

Unfortunately, I was wrong. Everywhere I turned people were quick to label my wife and I as parents-to-be. This is not just among radical pro-abortion activists who reduce pre-born humans to cell clusters, but even on major parenting websites: Parents.com, Parenting.com, and TheBump.com all regularly use the language dad-to-be when referring to men with unborn children.

Its an egalitarian problem as well: People.com called Beyonc a mom-to-be after her announcement of her pregnancy with twins. The language of future parenthood applied to couples celebrating their current pregnancy permeates our culture.

Look up the word father. Merriam-Webster gives a good clear definition: A man who has begotten a child. That is about as clear as it gets. A father is a man with a child. That means any man who has impregnated a woman is a father.

Our culture gets it exactly backward: Every man who has not yet reproduced including my son, still in utero is a father-to-be, by virtue of his potential ability to impregnate a woman. I was once a father-to-be, until my wife became pregnant. At that moment, even before we found out, I was, and always will be, a father.

This inversion of language, ingrained in even our parenting culture, needs to be addressed for several reasons. Im a theology nerd, so heres a theology nerd analogy to help illuminate the problem: At the Council of Ephesus in 431 AD, bishops of the church met to decide what to call Mary. Was she merely Christotokos, or Christ-bearer, as Nestorius asserted? Or was she Theotokos, the bearer of God?

The council found in favor of Theotokos, because they recognized that the title we give Mary is really dependent on who we think Christ is. In other words, what we say about the blessed virgin is really a confession about her son. So also, in the matter at hand, those who use the terms mother- or father-to-be are really making a statement about the child. That statement needs to change.

As much as the Left likes to think of conservatives as science deniers on points like global warming, its difficult for them to maintain any moral high ground when their rhetoric on the unborn is so anti-science. Take Bill Nyes now infamous appearance on Big Thinks YouTube channel. As Professor Robert George and bioethicist Patrick Lee note in their response to Nye, the only science Nye cites is that fertilized eggs spontaneously abort pre-implantation at a very high rate.

After that, he just does bad philosophy. They quote several embryology textbooks that explain how and why unique human life begins at conception. A recent study has demonstrated that, even before implantation, a human embryo is autonomous and seeks its own growth and good. Thats some science, guy.

Even when abortion is not specifically in view, it is just as science-denying to use to be when speaking of parents. The human in utero is fully human, and when we casually dismiss this tiny, precious human, we dismiss and disrespect so much more of the human experience.

The language of future or potential parenthood is disrespectful to the parents of miscarried babies. Society grieves when parents lose their born children. We recognize that nature is disordered in a horrendous way when this takes place. But if we continue to talk about parents of pre-born children as if they are not really parents yet, we deny the legitimate grief of parents who lose their children to miscarriage.

Like parents who have lost born children, the mothers and fathers who have lost children to miscarriage do grieve. The American Psychological Association reported one study that indicates 15 percent of female participants who had a miscarriage had clinically significant depression and/or anxiety during and after pregnancies for up to three years.

The language our culture uses actively devalues the babies these parents have lost. Those using the epithets mom- or dad-to-be might as well tell parents that their grief over a miscarried child is as inappropriate as a woman grieving over her period. Both are merely potential children, not children in themselves. So on top of the grief of a lost child, parents have to deal with a society that doesnt even recognize their grief as legitimate.

My wife has already lost hundreds of hours of sleep to the myriad discomforts of pregnancy. On top of that, she has spent much of time exhaustedas her body provides for the miraculous development of the baby in her womb. She has made sacrifices that I cannot even begin to understand as she participates in this wonderment.

None of this is to paint a bleak picture of pregnancy. My wife will be the first to tell you how much she loves this time of our lives. But calling her a mom-to-be diminishes my wifes important contributions and sacrifices in her vocation as mother.

Not that I have yet made sacrifices to rival those of my wife, but I, too, see this language as an attack on my vocation. I work a full-time job as the sole breadwinner in our house now that my wife is pregnant, simultaneously maintaining high marks and a full school schedule. All of this is a life I have chosen for the sake of my wife and son it is my responsibility to protect and provide for my pre-born child. When people refer to a father who is working hard to provide for his partners comfort and to prepare for the birth of their child as a father-to-be, it devalues the vocation of father that he has already taken upon himself.

It is rarely disputed that fathers have responsibilities to their children. Our society has enacted child support laws specifically to ensure that fathers fulfill their duty to provide for their children, under penalty of law. We have said that it is wrong for a man to abandon children he has fathered.

But when we call a man a father-to-be, we are saying he does not yet have these responsibilities. Thus we should not be surprised when we hear stories in which men pressure women to kill their children by abortion, as Mark and Nathan Hamill reportedly did not too long ago, in this very galaxy.

I now actually look forward to people calling me a father-to-be, even though its also a pet peeve.

C.S. Lewis put it well: In a sort of ghastly simplicity we remove the organ and demand the function. We make men without chests and expect of them virtue and enterprise. We laugh at honour and are shocked to find traitors in our midst. We castrate and bid the geldings be fruitful. In this case, we dont call men fathers, and are aghast at them refusing to father well.

I now actually look forward to people calling me a father-to-be, even though its also a pet peeve. People who are pro-life often dont know how to talk to others about their convictions. Its not easy to bring abortion up in casual conversation. Its a taboo subject, and expressing your pro-life beliefs can result in losing friends, or worse. One teacher in Canada even lost his job because he expressed his pro-life views.

But here, far removed from the abortion conversation, when someone calls me a father-to-be I can ask what exactly he mean by it. I can question her position without ever mentioning abortion. I can ask what he thinks my child is, whether he is human, and all sorts of other questions, all without getting the other persons guard up. So now I thank God every time someone calls me a father-to-be.

Jonathan Graham is a husband, father, and Lutheran layman studying classics and creative writing in Charleston, South Carolina. You can follow him on Twitter: @johnnyis_.

See the original post here:
5 Reasons To Stop Calling Dads Of Unborn Babies A 'Father To Be' - The Federalist